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Abstract
Objective- Determine the effectiveness of shared decision making to 1) increase
decisional comfort with the appropriate use of antibiotics for respiratory tract
infections and 2) maintain antibiotic prescribing rates at current levels.
Participants- English speaking college students age 18 and over diagnosed with a
respiratory tract infection in the general medical clinic of a university health
center from August 31, 2015-May 6, 2016.
Methods- Pre- and post-intervention surveys used to measure decisional conflict
of students. Intervention included staff training in shared decision making and the
use of a decision aid in clinical practice.
Results- Students who received routine care were 2.2 times more likely to
experience decisional conflict than students whose care included the decision aid.
Antibiotic prescribing rates where maintained at pre-intervention levels.
Conclusions- Use of a decision aid show promise to increase comfort with the
appropriate treatment of respiratory tract infections while maintaining current
prescribing rates.
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Introduction and Background
The World Health Organization (2012) reports that antibiotic resistance is a
global health emergency which poses a serious threat to modern medicine; making the
inability to treat common illnesses and injuries no longer a fantasy, but a real possibility.
Overuse of antimicrobials correlates directly with antibiotic resistance within a
population (World Health Organization, 2012). Viral respiratory tract infections are a
major cause of antibiotic use, even though there is no evidence to support their use for
these infections (Kenealy & Arroll, 2013; World Health Organization, 2012). In
September 2014 the White House released the National Strategy for Combating
Antibiotic-resistant Bacteria. Goal one of this strategy calls for the cooperation of
providers and patients to strengthen antibiotic stewardship.
Numerous interventions have been studied to decrease the inappropriate use of
antibiotics for respiratory tract infections; however, no one intervention has been
identified as best practice (Tonkin-Crine, Yardley, & Little, 2011). The idea of improved
provider-patient communication and patient centered care, in the form of shared decision
making, has been gaining attention as a possible intervention (Briel et al. 2006; Elwyn et
al., 2012; Haltiwanger et al. 2001; Welschen et al., 2004; Zoorob et al., 2001). Shared
decision making is defined as the interactional exchange of information and deliberation
between a health care provider and patient (Légaré et al., 2013b). Traditional provider
patient interactions are passive in that the provider makes the decision without input from
the patient (Elwyn et al., 2012; Légaré et al., 2013a). Shared decision making is a process
which encourages patients to move from the traditional passive interaction to a
collaborative interaction.( Légaré et al., 2013a). The process includes providing the
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patient with the best evidence regarding the risks and benefits of their condition and
exploring the patient’s values and perceptions (Elwyn et al., 2012; Légaré et al., 2013a).
Review of Literature
Evidence based guidelines for the treatment of respiratory tract infections are
readily available to providers; however, biomedical aspects are not the only factors that
affect provider’s decisions to prescribe antibiotics. Patient perceptions and expectations
are often the reason unnecessary antibiotics are prescribed (Altiner et al., 2007; Briel et
al., 2006). While education is important, a focus should be placed on provider-patient
communication to effectively decrease the use of antibiotics for respiratory tract
infections (Altiner et al., 2007).
College health providers are not immune to challenges related to the ethical
treatment of viral respiratory tract infections and often deal with pressures to prescribe
unnecessary antibiotics for students. In addition, college health centers are in a unique
position to educate students regarding the appropriate treatment of respiratory tract
infections, promoting life-long stewardship of antibiotics (Haltiwanger et al., 2001;
Zoorob et al, 2001). The idea of improved provider-patient communication, including
shared decision making, shows promise for use with college students. Young adults have
been found to prefer, and even expect, shared decision making when consulting with
health care providers (Alden, Merz, & Akashi, 2012; Briel et al., 2007). In addition, an
increase in education level correlates with an increase in preference for shared decision
making (Briel et al., 2007).
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A systematic literature review evaluating the use of shared decision making for
respiratory tract infections in college students was completed during fall 2014 and serves
as the background of evidence for this project. The manuscript of this systematic review
was published in the May-June 2016 issue of the Journal of American College Health
(Blyer and Hulton, 2015).
Problem Statement
The unnecessary use of antibiotics for viral respiratory tract infections contributes
to antibiotic resistance. Patient perceptions and expectations often lead to the unnecessary
use of antibiotics. The question to be answered from the implementation of this project is,
“Does the use of shared decision making within the college health setting increase
student decisional comfort with the ethical use of antibiotics while maintaining low
antibiotic prescribing rates for viral respiratory tract infections?”
Theoretical Model
The Ottawa Research Institute (2014) five step process for implementation of a
shared decision making intervention was used as a guide for the implementation process.
This process is based on the Knowledge to Action Cycle (McDavid, Huse, and Hawthorn,
2013) and includes the following steps:
1) Identify the decision;
2) Find patient decision aids;
3) Identify barriers and explore ways to over them;
4.1) Implement decision aids and support;
4.2) Provide training; and
5) Monitor use and outcomes.
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See Figure 1 for a depiction of a logic model for this project.
Project Description
The project was conducted as a quality improvement project implementing shared
decision making into a college health clinic. Implementation included the use of the
decision aid, “Taking an Antibiotic or Not? Acute Respiratory Tract Infections (ARI)” by
Labrecque, LeBlance, Légaré, and Cauchon (2010). Permission to use the aid was
received in writing from the author.
Objectives
Objectives for this project include:
1) To increase student comfort with the appropriate use of antibiotics for
respiratory tract infections.
2) To maintain antibiotic prescribing rates at current rate or lower.
The vision of the University Health Center’s strategic plan is, “To be the model
for translating health care and health education into increased student engagement and
learning.” One objective of this plan is to, “Ensure that our educational programs include
intentional opportunities for students to learn ethical decision-making skills.” The
objectives for this project directly related to the organizations strategic plan by engaging
students in learning about their health and ethical decision making skills related to the
appropriate, or ethical, use of antibiotics for respiratory tract infections.
Pre-intervention prescribing rates for respiratory tract infections in the Health
Center’s General Clinic are around 33%. According to a Cochrane Review by Coxeter et
al. (2015) shared decision making was shown to decrease prescribing rates from 47% to
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29%. Briel et al. (2006) found that shared decision making did not decrease prescribing
rates for providers with already low prescribing rates. An initial assessment of
perceptions related to shared decision making identified provider concerns that shared
decision making would increase prescribing rates. Considering the fact that the providers
already have relatively low prescribing rates, shared decision making is not shown to
decrease low prescribing rates, and the provider’s concerns about increased prescribing,
objective two, was focused on maintaining prescribing rates at current levels and not
necessarily on lowering prescribing rates.
Project Design
Setting and Resources
The project took place in the General Medicine Clinic at the James Madison
University Student Health Center located in Harrisonburg, Virginia. The University has a
population in excess of 20,000 students and the health center provides in excess of 30,000
student visits per year. Respiratory tract infections account for approximately 5000
student visits per year. Funding for the project was provided through the James Madison
University Student Affairs Innovation Grant.
Study Population
Four providers from the General Medicine Clinic, including two physicians and
two nurse practitioners, agreed to participate in the study. Project participants included
English speaking patients 18 years and older who made an appointment with participating
providers at the University Health Center General Medicine Clinic between August 31,
2015 and May 6, 2016 and who were diagnosed with an upper respiratory tract infection.
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Design
Prior to the start of the study all General Clinic providers were offered
participation in the study through direct contact. All Health Center staff, including
providers, where offered access to training whether or not they participated in the study.
See Appendix A for a copy of the provider consent form.
The pre-implementation phase of the project took place from August 31, 2015 to
December 18, 2015. During the pre-implementation phase participating providers offered
students diagnosed with a respiratory tract infection participation in the study through an
anonymous survey. Students who choose participation in the study completed the one
page survey in a waiting area located at check-out and placed it in a locked drop box.
Please see Appendix B for a copy of the patient cover/consent and survey (survey was
distributed as a single front and back document). Surveys were color coded per provider.
In December, following the pre-implementation phase, participating providers as
well as all other Health Center staff were offered shared decision making training using
online training videos developed using the Agency for Healthcare Research and Quality
(AHRQ) SHARE program. On January 8th, 2016 a hands-on clinical training was also
offered. The training included an interprofessional role play and discussion of shared
decision making followed by hands-on practice. The practice sessions included volunteer
student patients who acted out case studies. This allowed the providers to practice with
patients in their own exam rooms to increase comfort with the intervention.
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The post-intervention phase of the project took place from January 11, 2016 to
May 6, 2016. During the post-intervention phase providers had the option of using the
decision aid for patients with symptoms of a respiratory tract infection. Students were
offered participation in the study using the same survey and method as during the preintervention phase. The use of a decision aid was specified by providers on the bottom of
the patient survey. See Figure 2 for a visual depiction of the project timeline.
Sources of Data
Antibiotic prescribing rates for respiratory tract infections will be collected during
both pre-and post- intervention phases using data from the Health Center’s electronic
health record (EHR) system. EHR reports created for this data included ICD-9/ICD-10
codes for respiratory tract infections to account for the coding changes that occurred
during the study. Reports also included the transaction codes for antibiotics commonly
used for respiratory tract infections.
Patient decisional comfort was assessed pre- and post- intervention using the
SURE test© located on the patient survey (see Appendix A). Permission to use the test
was obtained in writing from the author. The four items on the SURE test© are summed
to determine the decisional conflict score for each individual. Scores range from
extremely high decisional conflict (0) to no decisional conflict (4). A score of ≤ 3
indicates decisional conflict is present (O’Conner, 1993). A summary of data variables
can be found in Table 1.
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Within one week of study implementation providers reported that the student
population was making decisions quickly without needing to complete all six steps of the
decision aid. Providers felt that completing the final steps after students declared their
decision was redundant and unnecessary. Upon being made aware of this phenomenon
the researchers received IRB approval to add a Provider Use of Decision Aid Survey to
the end of the implementation phase (See Appendix C). The purpose of the additional
survey was to assess the extent of DA use.

Special Note
The original project proposal and subsequent IRB addendum included surveys on
provider intent, use of shared decision making, qualitative feedback, and visit time
studies. Data collected which relates to providers does not directly relate to the objectives
for this portion of the study and will not be reported in this executive summary. A
subsequent data analysis and manuscript based on provider data will be considered at a
later time.
Evaluation Plan
Data analysis will be completed using SPSS. Decisional conflict directly links to
objective one and was measured using the SURE test© (see description above). Odds
ratio was used to determine the effect of each predictor variable on the outcome of
decisional conflict. Antibiotic prescribing rates directly link to objective two and were
measured using EHR data to determine the percentage of antibiotics prescribed for
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patients diagnosed with respiratory tract infections. Please see Figure 3 and Table 2 for a
list of respiratory diagnoses and antibiotics used to determine prescribing rates.

Findings
The decision aid was the only statistically significant predictor of decisional
conflict. Those who did not have the decision aid used in consultation were almost 2.2
times more likely than those who did to experience decisional conflict [N=643; p=<.001;
95% CI (1.55, 3.12)]. See Table 3 for complete Variables Results. Antibiotic prescribing
rates did not show any significant difference with antibiotics being prescribed 33.3% of
the time pre-intervention and 31.7% of the time post-intervention [X (1, N=3174)=.922,
2

p= .337].
When using a decision aid all providers reported using steps one and two “almost
always”. Half of the providers reported using steps three and four “almost always” and
half reported using steps three and four “sometimes”. Step five was reportedly used from
“not at all” to “almost always”. Step six of the decision aid was the least used with
reported use ranging from “not at all” to “sometimes”.
The findings answered the question proposed in the project problem statement.
The use of shared decision making, through the use of a decision aid, increased student
comfort by over two times that of usual care while maintaining current antibiotic
prescribing rates for respiratory tract infections. Likewise, the study also met both
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objectives by increasing student comfort with appropriate antibiotic prescribing rates
while maintaining current prescribing rates.
The most significant barrier to the study was the varied use of the decision aid.
The most significant motivation to the use of the shared decision making was steps one
and two of the decision aid which educated students on the probability that their
symptoms where bacterial. The providers felt that these steps were the most beneficial
communication and educational tools for use during the visit. Providers felt that students
where often quick to make decisions about the use of antibiotics based in this probability.
No other unintended consequences or findings were identified.
Recommendations/Implications
Haltiwanger, et al. (2001) identified the antibiotic-seeking behaviors of college
students, reporting that 55% of students being seen for a respiratory tract infections
expected to receive an antibiotic while only 36% received a prescription for an antibiotic.
This study identified a clear diagnosis, explanation for treatment, and a prescription for
an antibiotic as being significantly associated with patient satisfaction. Fifteen years later
college health centers still struggle with student dissatisfaction when not receiving
antibiotics for respiratory tract infections and cannot ignore the call to change prescribing
practices while educating patients about the appropriate use of antibiotics (Blyer and
Hulton, 2016). In the current study, the decision aid, “Taking an Antibiotic or Not?” was
shown to be an effective intervention to improve college student decisional comfort with
the appropriate use of antibiotics for respiratory tract infections. In addition, the
intervention was shown to increase decisional comfort without increasing already low
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antibiotic prescribing rates. College health centers should consider implementation of the
decision aid to increase students comfort and promote the appropriate use of respiratory
tract infections.
This study identifies many implications for further studies. Future studies should
focus on the effectiveness of the decision aid in varied college health settings including
those serving large numbers of international students. In addition, further work should
also identify which steps of the decision aid are most effective for the college population
and use this information to adapt the decision aid for the population. Assessment and
measurement of student learning related to the use of the decision aid would also be
valuable data and should be considered for future studies.
According to Elwyn, G., Frosch, D., and Kobrin, S. (2016) the future of shared
decision studies lies in a broader conceptualization and measurement of the practice.
Considering these recommendations along with the findings from this study future
studies should also focus on long term outcomes of the intervention. For the purpose of
this study immediate prescribing rates were reported but no other prescribing rates where
available. Future studies should focus on longer term outcomes such as re-consultation
rates and prescribing rates within the days and weeks following the initial use of the
decision aid.
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Appendix

Appendix A
Provider Consent

Consent to Participate in the Project on Shared Decision Making for the
Ethical Use of Antibiotics
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Kristina B. Blyer, MSN, RN, NE-BC
from James Madison University. The purpose of this study is to assess the use of shared decision making
for the ethical use of antibiotics. This study will contribute to the researcher’s completion of Doctor of
Nursing Practice (DNP).

Research Procedures
Should you decide to participate in this research study, you will be asked to sign this consent form once
all your questions have been answered to your satisfaction. This study consists of a survey that will be
administered to individual participants at four points throughout the study. You will be asked to provide
answers to a series of questions related to the use of shared decision making for students consulting
with respiratory tract infections. In addition, participants will be asked to distribute patient surveys
following consultation for respiratory tract infections.

Time Required
Participation in this study will require 10 minutes of your time per survey. Surveys will be given in at four
points during the study for a total of 30 minutes. Patient surveys will be distributed with visit encounter
form and should require less than 30 seconds of time for each patient.

Risks
The investigator does not perceive more than minimal risks from your involvement in this study (that is,
no risks beyond the risks associated with everyday life).

Benefits
There are no direct benefits for participation in the study. Study finding will contribute to general
knowledge regarding the use of shared decision making for respiratory tract infections.

Confidentiality
The results of this research will be presented to health center staff and administrators, at conferences,
and in manuscript format. The researcher retains the right to use and publish non-identifiable data.
While individual responses are obtained and recorded anonymously and kept in the strictest confidence,
aggregate data will be presented representing averages or generalizations about the responses as a
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whole. All data will be stored in a secure location accessible only to the researcher. Upon completion of
the study, all records will be destroyed.

Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate. Should you choose to
participate, you can withdraw at any time without consequences of any kind.

Questions about the Study
If you have questions or concerns during the time of your participation in this study, or after its
completion or you would like to receive a copy of the final aggregate results of this study, please
contact:

Kristina B. Blyer, MSN, RN, NE-BC
University Health Center

Dr. Maria DeValpine
Nursing Department

James Madison University

James Madison University

blyerkb@jmu.edu

devalpmg@jmu.edu

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu

Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in this
study. I freely consent to participate. I have been given satisfactory answers to my questions. The
investigator provided me with a copy of this form. I certify that I am at least 18 years of age.
______________________________________
Name of Participant (Printed)
______________________________________ ______________
Name of Participant (Signed)

Date

______________________________________ ______________
Name of Researcher (Signed)

Date
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Appendix B
Patient Cover Letter and Survey
Cover Letter for Project on Shared Decision Making for the Ethical Use of Antibiotics (Page 1)
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Kristina B. Blyer, RN, MSN, NE-BC from James
Madison University. The purpose of this study is to assess the use of shared decision making for the ethical use of
antibiotics. This study will contribute to the researcher’s completion of her doctoral capstone project.

Research Procedures
This study consists of a survey that will be administered to individual participants in the University Health Center
following a visit for symptoms of a respiratory tract infection. You will be asked to provide answers to a series of
questions related to your preferred treatment for respiratory tract infections and your decisional comfort with this
preferred treatment.

Time Required
Participation in this study will require 2 minutes of your time.

Risks
The investigator does not perceive more than minimal risks from your involvement in this study (that is, no risks
beyond the risks associated with everyday life).

Benefits
There are no direct benefits for participation in the study. Study finding will contribute to general knowledge
regarding the use of shared decision making for respiratory tract infections.

Confidentiality
The results of this research will be presented to health center staff and administrators, at conferences, and in
manuscript format. While individual responses are obtained and recorded anonymously and kept in the strictest
confidence, aggregate data will be presented representing averages or generalizations about the responses as a
whole. No identifiable information will be collected from the participant and no identifiable responses will be
presented in the final form of this study. All data will be stored in a secure location accessible only to the
researcher. The researcher retains the right to use and publish non-identifiable data. At the end of the study, all
records will be destroyed.

Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate. Should you choose to
participate, you can withdraw at any time without consequences of any kind. However, once your responses have
been submitted and anonymously recorded you will not be able to withdraw from the study.

Questions about the Study
If you have questions or concerns during the time of your participation in this study, or after its completion or you
would like to receive a copy of the final aggregate results of this study, please contact:
Kristina B. Blyer, MSN, RN, NE-BC
Dr. Maria DeValpine
University Health Center
Nursing Department
James Madison University
James Madison University
blyerkb@jmu.edu
devalpmg@jmu.edu

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
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James Madison University
(540) 568-2834
cocklede@jmu.edu

Giving of Consent
I have read this cover letter and I understand what is being requested of me as a participant in this study. By
completing this survey I consent to participate. I have been given satisfactory answers to my questions. I certify
that I am at least 18 years of age.
__Kristina B. Blyer____________________________________
Name of Researcher (Printed)
__________(Signature)_______________ ______________
Name of Researcher (Signed)
Date
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Treatment Preference and Decisional Comfort Survey (page 2)
Please complete the following questions; all answers are anonymous.
Which option for the treatment of respiratory tract infections (colds, sinus infections, sore throat,
bronchitis, or ear infections) do you expect? Please check one.
a.
b.
c.
d.

Antibiotics
Non-antibiotic treatment
Whatever my medical provider recommends based on my symptoms
Unsure

When making decisions about the treatment of respiratory tract infections:
Yes

No

[1]

[0]

Do you feel SURE about the best choice for you?
Do you know the benefits and risks of each option?
Are you clear about which benefits and risks matter
most to you?
Do you have enough support and advice to make a
choice?
Adapted from the SURE Test© O’Conner and Légaré, 2008.

How do you identify?
Male
Female
What is your age? _______

Other

What year are you at JMU?
Freshman

Sophomore

Junior

Senior

Graduate

Have you completed this questionnaire (since “August 2015 or January 2016”)?
Yes

No

When completed, please place this form in the secure drop box located at the check-out
desk. Thank you for
your participation!
Provider use only:
DA
Yes

No
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Appendix C
Provider Use of Decision Aid
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Table 1
Variables Table
Dependent Brief
(Outcome) Description
Variable
Decisional
Comfort

4-item tool to
assess clinically
significant
decisional
conflict in
patients

Data
Source

Possible Range of
Values

Reference

Time Frame for collection

Patient
survey-SURE
tool

Items are given a score
value of: 0= no and 1= yes

Ferron Parayre et al. [1]
(2014)

Pre-intervention
August 31, 2015- December 18,
2015

Items are summed and
scores rage from 0
[extremely high decisional
conflict] to 4 [no decisional
conflict]

O’Conner [3] (1993)
Post-intervention
Jan. 11, 2016- May 6, 2016

Score of ≤ 3 indicates
decisional conflict

Predictor
Variable

Brief
Description

Data
Source

Possible Range of
Values

Reference

Time Frame for collection

Antibiotic
prescribing

Antibiotic
prescribing
rates for
respiratory
tract infections
(RTIs)

EHR

Percentage of antibiotics
prescribed for RTIs.

N/A

Pre-intervention

Rates

August 31, 2015- December 18,
2015
ICD-9/ICD-10 codes
Post-intervention
Jan. 11, 2016- May 6, 2016

Antibiotic transactions
codes

Patient sex

Sex with which
patient
identifies

Patient
survey

Male

N/A

Pre-intervention
August 31, 2015- December 18,
2015

Female
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Other

Post-intervention
January 11, 2016- May 6, 2016

Patient Age

Age at time of
visit

Patient
Survey/

18-99

N/A

Pre-intervention
August 31, 2015- December 18,
2015

EHR

Post-intervention
January 11, 2016- May 6, 2016
Year in
College

Year at JMU

Patient
Survey/EHR

Freshman

N/A

Pre-intervention
August 31, 2015- December 18,
2015

Sophomore
Junior
Senior

Post-intervention
Graduate
January 11, 2016- May 6, 2016
Treatment
Expectations

Patient’s
preference for
treatment of
RTIs

Patient
survey

-Antibiotics
-Non-antibiotic treatment
options

Developed per
O’Conner [3] (1993) as a
preliminary question
for the SURE tool

-Whatever my provider
recommends

Use of decision
aid “Taking and
Antibiotic or
Not?”

EHR and
patient
survey
(provider
reported)

Yes
No

August 31, 2015- December 18,
2015

Post-Intervention

-Unsure
Use of
Decision Aid

Pre-intervention

January 11, 2016- May 6, 2016
N/A

Pre-intervention
August 31, 2015- December 18,
2015
Post-Intervention
January 11, 2016- May 6, 2016

1. Ferron Parayre, A., Labrecque, M., Rousseau, M., Turcotte, S., & Legare, F. (2014). Validation of
SURE, a four-item clinical checklist for detecting decisional conflict in patients. Medical Decision
Making : An International Journal of the Society for Medical Decision Making, 34(1), 54-62.
2. O’Conner, A. M. (1993). User manual- decisional conflict scale [updated 2010]. Retrieved from
https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Conflict.pdf
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Table 2
List of Antibiotics
Condition

Comment

Otitis Media

Medication
Amoxicillin

In House

Alchemy

IHAmox875

R10250
R18555

Amox/clav
2nd gen ceph

IHAmxClv14

R21832

IHAmoxClav

R2172

cefuroxime

Rcefurox
Rcefurox_1
Rcefurox_2
Rcefurox_3
RCeftin2
RCeftin5

Cefprozil

Rcefproz
RCefproz2
RCefzil2
RCefzil5

3rd gen ceph

Cefdinir

Rcefdini
Rcefdind_2
Rcefdini_5
Romnicef
Romnicef_1

formerly Vantin

Cefpodoxime

Less effective

Azithromycin

Rcefpodo
IHAzith250

R37088
Razithro_1
Rzithrom
Rzithrom_2

"

"

Clarithromycin

Rclarith
Rclarith_3
RBiaxinF
RBiaxinF_3

"
Pharyngitis

"

Preferred

SMZ-TMP

IHSmzTmp 14,
28, 40

Penicilin V

IHPen50030

R3651

IHPenV500

Rpenicil

Amoxicillin

As above
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(occassionalabscess)

Amox/clav

As above

1st generation
cephalosporin

cephalexin

IHCephalex

R14486
R5773
R3521

(seldom)

Erythromycin

R7288
R9637
R53475
Rerythro_6
Rerythro_7
Rerythro_8

(Abscess)_

Clindamycin

IHClind150

Rclindam
Rcleocin
R49454
R47779

Less effective
Sinusitis

Azithromycin

as above

Amox/clav

as above

Doxycycline

IHDoxy14

R22787
R24676
R37415

Bronchitis

Azithromycin

as above

Amoxicillin

as above

Amox/clav

as above

rarely 2nd, 3rd
cephalosporin

as above

as above

rarely doxycycline

as above

rarely
fluoroquinolone

Levofloxacin
Levaquin

Rlevaqui
Rlevaqui_1
Rlevaqui_2

Moxifloxacin
Avelox

RAvelox4
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Table 3
Variable Results
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Figure 1
Logic Model
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Figure 2
Timeline for Project
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Figure 3
ICD 9/10 Diagnosis Codes

Dx Code

Description

J20

Acute Bronchitis
Acute nonsuppurative otitis media, unspecified
Acute serous otitis media
Acute suppurative otitis media without spontaneous rupture of eardrum
Unspecified otitis media
Pain in Throat
Acute nasopharyngitis [common cold]
Acute sinusitis
Acute maxillary sinusitis
Acute frontal sinusitis
Acute pharyngitis
Acute tonsillitis
Acute upper respiratory infections of unspecified site
Acute bronchitis
Acute laryngitis and tracheitis
Allergic rhinitis, unspecified
Acute allergic serous otitis media
Acute suppurative otitis media with spontaneous rupture of eardrum
Acute suppurative otitis media in diseases classified elsewhere
Allergic rhinitis
Allergic rhinitis due to animal (cat) (dog) hair and dander
Allergic rhinitis due to other allergen
Allergic rhinitis, cause unspecified

38100
38101
38200
3829
r070
460
461
4610
4611
462
463
4659
4660
J04
J30.9
38104
38201
38202
477
477.2
477.8
477.9

